Evidence map›Paper›PMID 36764426›Full record

Observational studyAmerican journal of ophthalmology2023

Static Perimetry in the Rate of Progression in USH2A-related Retinal Degeneration (RUSH2A) Study: Assessment Through 2 Years.

Jacque L Duncan, Peiyao Cheng, Maureen G Maguire, Allison A Ayala, David G Birch, Janet K Cheetham, Todd A Durham, Abigail T Fahim, Carel B Hoyng, Hiroshi Ishikawa and 6 more

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in American journal of ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 11 institutions in 5 countries.

Jacque L DuncanFrom the University of California, San Francisco (J.L.D.), San Francisco, California, USA.
Peiyao ChengJaeb Center for Health Research (P.C., M.G.M., A.A.A.), Tampa, Florida, USA.
Maureen G MaguireJaeb Center for Health Research (P.C., M.G.M., A.A.A.), Tampa, Florida, USA.
Allison A AyalaJaeb Center for Health Research (P.C., M.G.M., A.A.A.), Tampa, Florida, USA. Electronic address: ffbcorrespauth@jaeb.org.
David G BirchRetina Foundation of the Southwest (D.G.B.), Dallas, Texas, USA.
Janet K CheethamFoundation Fighting Blindness (J.K.C., T.A.D.), Columbia, Maryland, USA.
Todd A DurhamFoundation Fighting Blindness (J.K.C., T.A.D.), Columbia, Maryland, USA.
Abigail T FahimKellogg Eye Center, University of Michigan (A.T.F.), Ann Arbor, Michigan, USA.
Carel B HoyngRadboud University Medical Center (C.B.H.), Nijmegen, the Netherlands.
Hiroshi IshikawaCasey Eye Institute, Oregon Health & Science University (H.I., M.E.P.), Portland, Oregon, USA.
Michel MichaelidesMoorfields Eye Hospital and UCL Institute of Ophthalmology (M.M.), London, United Kingdom.
Mark E PennesiCasey Eye Institute, Oregon Health & Science University (H.I., M.E.P.), Portland, Oregon, USA.
José-Alain SahelInstitut de la Vision, Sorbonne Université, INSERM, CNRS (J.A.-S.), Paris, France; Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, INSERM-DGOS CIC1423 (J.A.-S.), Paris, France; Department of Ophthalmology, The University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Katarina StinglUniversity Eye Hospital, Center for Ophthalmology, University of Tübingen (K.S.), Tübingen, Germany; Center for Rare Eye Diseases, University of Tübingen, Tübingen (K.S.), Germany.
Christina Y WengBaylor College of Medicine (C.Y.W.), Houston, Texas, USA.
Foundation Fighting Blindness Consortium Investigator Group
Jaeb Center for Health Research · USFoundation Fighting Blindness · USOregon Health & Science University · USBaylor College of Medicine · USCentre National de la Recherche Scientifique · FRMoorfields Eye Hospital NHS Foundation Trust · GBRadboud University Nijmegen · NLRetina Foundation of the Southwest · USSTZ eyetrial · DEUniversity of California, San Francisco · USUniversity of Michigan · US

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LAKKARAJU, APARNA · 1985 to 2024
$16.8M
MEASURES OF HUMAN RECEPTOR AND POST RECEPTOR ACTIVITYR01EY009076 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BIRCH, DAVID G, HOOD, DONALD C. · 1991 to 2021
$8.3M
Investigating Membrane Trafficking Deficits in ChoroideremiaK08EY032991 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FAHIM, ABIGAIL · 2021 to 2023
$713k
NEI NIH HHS K08 EY032991NEI NIH HHS P30 EY002162NEI NIH HHS R01 EY009076
6 · The paper itself

Abstract

purposeTo evaluate disease progression using static perimetry (SP) in patients with USH2A-related retinal degeneration, including Usher syndrome type 2 (USH2) and nonsyndromic autosomal recessive retinitis pigmentosa.

designProspective, observational cohort study.

methodsA total of 102 patients with biallelic disease-causing sequence variants in USH2A with baseline best-corrected visual acuity (BCVA) letter score ≥54 were recruited from 16 clinical sites in Europe and North America. SP, BCVA, full-field stimulus thresholds, spectral domain optical coherence tomography macular scans, and fundus-guided mesopic microperimetry were performed at baseline and annually. The main outcome measures were total hill of vision (V

resultsThe average decline (95% CI) was 2.05 (1.40, 2.70) decibel-steradian (dB-sr)/y for V

conclusionsQuantitative measures of SP declined significantly over 2 years in USH2A-related retinal degeneration. The annual percentage rate of change was greatest for V

Indexed as

Retinal DegenerationUsher SyndromesExtracellular Matrix ProteinsHumansProspective StudiesTomography, Optical CoherenceVisual AcuityVisual FieldsVisual Field TestsExtracellular Matrix ProteinsUSH2A protein, human

Identifiers

PMID36764426
PMCPMC10705000
OpenAlexW4320032836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.